TrialBMC psychiatry2025

Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): a double-blind placebo-controlled randomized clinical trial.

Hasan Mirzazadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.